Dr. Robert Todd Lancaster, MD, MPH

Dr. Lancaster practices at Newton-Wellesley Hospital in Newton, Massachusetts, part of Mass General Brigham.

Dr. Lancaster's NPI, 1093773673, was assigned on May 3, 2006. Dr. Lancaster graduated from Emory School of Medicine in 2003. Dr. Lancaster holds Massachusetts license 227874.

Dr. Lancaster's primary practice is Newton-Wellesley Hospital, at 2014 Washington Street, Newton, MA 02462 in Middlesex County. The practice phone is (617) 243-6000.

Dr. Lancaster's primary practice is Newton-Wellesley Hospital in Newton, Massachusetts, part of Mass General Brigham. Dr. Lancaster is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Lancaster to 2 more hospitals, 5 medical groups, 4 group practices and clinics and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lancaster practices, 9 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Lancaster's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Lancaster is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Lancaster's licenses on file in 3 states: Massachusetts, New Hampshire and South Carolina.

Dmand AI lists amputation, aortic atherosclerois, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Lancaster treats.

CMS data shows 2,998 Medicare services from Dr. Lancaster across 30 procedure codes in 2024, for 989 Medicare patients. Medicare paid $700,297 for them.

CMS counts 989 Medicare patients who saw Dr. Lancaster in 2024. The largest group is 75 to 84, with 438 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lancaster's median patient age at 72, with 49% women.

In 2024, Dr. Lancaster wrote 55 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 33 of them, across 1 drug with 11 or more claims each, at $586 in total drug cost. In 2023, CMS named 68 claims across 2 drugs.

CMS lists Dr. Lancaster as offering telehealth. CMS counts 27 procedures of leg revascularization (restoring blood flow) by Dr. Lancaster, more than 87% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Lancaster, published from 2011 to 2021. 2012 was the busiest year, with 4. The most frequent topics are Postoperative Complications, Blood Vessel Prosthesis Implantation and Aortic Aneurysm, Abdominal. Dr. Lancaster has published most often in J Vasc Surg. Dr. Lancaster's most frequent co-authors are Virendra I. Patel, MD, MPH, Mark F. Conrad, MD and William D. Clouse, MD.

CMS Open Payments shows 139 general payments to Dr. Lancaster from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Nuvasive, Inc. paid the most, $3,253.

Dr. Lancaster graduated from Emory School of Medicine in 2003. Dr. Lancaster is a member of SVS.

Dr. Lancaster is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.